Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411810 · ClinicalTrials.gov registry record · NA
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT04411810 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 149 participants.
The verdict
NCT04411810, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
The overall goal of this research is to develop a platform that can increase patient access to expert skin cancer diagnostic services via telemedicine. This is especially important for medically underserved areas where melanoma outcomes are worse than in areas with greater access to in-person evaluations. If successful, the widespread availability of such services would be combined with public education efforts to encourage individuals with changing skin lesions to seek evaluation. With decreased travel times to high quality diagnostic services, such efforts may decrease the diagnosis of more advanced melanomas (with a concomitant increase in the diagnosis of earlier stage tumors), and potentially decrease melanoma mortality.
Interventions
- PROCEDURE Skin biopsy
- DEVICE Nevisense 3.0
- DEVICE Dermlite Cam
- DEVICE Barco Demetra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2023-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04411810
The ClinicalTrials.gov registry entry for NCT04411810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Skin biopsy is the first listed.
NCT04411810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04411810 about?
NCT04411810 is a clinical study titled "SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer". The overall goal of this research is to develop a platform that can increase patient access to expert skin cancer diagnostic services via telemedicine. This is especially important for medically underserved areas where melanoma outcomes are worse than in areas with greater access to in-person evalua...
What is the current status of trial NCT04411810?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2020-08-20. Estimated completion is 2023-03-04.
What interventions are being tested in trial NCT04411810?
The interventions under investigation include: Skin biopsy (PROCEDURE), Nevisense 3.0 (DEVICE), Dermlite Cam (DEVICE), Barco Demetra (DEVICE).
Who is sponsoring clinical trial NCT04411810?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.